CD163 and breast cancer: Expression of MMPs by cancer-associated fibroblasts and mononuclear inflammatory cells is associated with a worse prognosis in BC [458], and tumor-associated CD163+ and CD68+ macrophages (TAMs) in the tumor stroma are associated with higher stage and invasiveness in BC [459].